[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100555803":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":32,"centralContacts":36,"locations":46,"responsibleParty":106,"collaborators":109,"id":115,"slug":116,"hasResults":117,"nctId":118,"briefTitle":119,"officialTitle":120,"acronym":40,"eligibilityCriteria":121,"healthyVolunteers":117,"sex":122,"minAge":123,"maxAge":124,"enrollmentInfo":125,"targetDuration":40,"studyType":128,"phases":129,"briefSummary":131,"conditions":132,"keywords":138,"overallStatus":143,"whyStopped":40,"lastUpdateSubmitDate":144,"lastUpdatePostDateStruct":145,"startDateStruct":148,"completionDateStruct":150,"leadSponsor":152,"locationsCount":153},{"fullName":5,"class":6},"Medical University of Lublin","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Enteral nutrition fluid - ENF","EXPERIMENTAL","Enteral nutrition will be given continuously with glucose-Na-K Baxter 50 mg\u002Fml solution for infusion (GNAK)-both products to the gastrointestinal tract in the same volume.",[13],"Other: Enteral fluid",{"label":15,"type":10,"description":16,"interventionNames":17},"Intravenous fluid - IVF","Enteral nutrition will be given continuously to the gastrointestinal tract. GNAK will be given continuously intravenously in the same volume.",[18],"Other: Intravenous fluid",[20,26],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":24},"Enteral fluid","GNAK will be administered to the gastrointestinal tract with EN in the same volume.",[9],[25],"ENF",{"type":6,"name":27,"description":28,"armGroupLabels":29,"otherNames":30},"Intravenous fluid","Undiluted EN will be given to the gastrointestinal tract. GNAK, in the same volume, will be administered intravenously.",[15],[31],"IVF",[33],{"name":34,"affiliation":5,"role":35},"Michal Borys, MD, PhD","PRINCIPAL_INVESTIGATOR",[37,42],{"name":34,"role":38,"phone":39,"phoneExt":40,"email":41},"CONTACT","+48 506350569",null,"michalborys1@gmail.com",{"name":43,"role":38,"phone":44,"phoneExt":40,"email":45},"Pawel Piwowarczyk, MD, PhD","+48 511285352","piwowarczyk.pawel@gmail.com",[47,62,74,88,94],{"facility":48,"status":40,"city":49,"state":40,"zip":50,"country":51,"countryCode":52,"cosmosGeoPoint":53,"geoPoint":58,"contacts":59},"Provincial Hospital in Gorzow Wielkopolski","Gorzów Wielkopolski","66-400","Poland","PL",{"type":54,"coordinates":55},"Point",[56,57],15.22505,52.73371,{"lat":57,"lon":56},[60],{"name":61,"role":38,"phone":40,"phoneExt":40,"email":40},"Miroslaw Czuczwar, MD, PhD",{"facility":63,"status":40,"city":64,"state":40,"zip":65,"country":51,"countryCode":52,"cosmosGeoPoint":66,"geoPoint":70,"contacts":71},"Fifth Military Hospital","Krakow","30-901",{"type":54,"coordinates":67},[68,69],19.93658,50.06143,{"lat":69,"lon":68},[72],{"name":73,"role":38,"phone":40,"phoneExt":40,"email":40},"Wojciech Szczeklik, MD, PhD",{"facility":75,"status":40,"city":76,"state":40,"zip":77,"country":51,"countryCode":52,"cosmosGeoPoint":78,"geoPoint":82,"contacts":83},"First Military Hospital","Lublin","20-049",{"type":54,"coordinates":79},[80,81],22.57009,51.25058,{"lat":81,"lon":80},[84],{"name":85,"role":38,"phone":86,"phoneExt":40,"email":87},"Elzbieta Rypulak, MD, PhD","+48791127036","elzbieta.rypulak@gmail.com",{"facility":89,"status":40,"city":76,"state":40,"zip":90,"country":51,"countryCode":52,"cosmosGeoPoint":91,"geoPoint":93,"contacts":40},"II Department of Anesthesia and Intensive Care, Medical University of Lublin","20-081",{"type":54,"coordinates":92},[80,81],{"lat":81,"lon":80},{"facility":95,"status":40,"city":96,"state":40,"zip":97,"country":51,"countryCode":52,"cosmosGeoPoint":98,"geoPoint":102,"contacts":103},"Provincial Hospital in Opole","Opole","45-372",{"type":54,"coordinates":99},[100,101],17.92604,50.67119,{"lat":101,"lon":100},[104],{"name":105,"role":38,"phone":40,"phoneExt":40,"email":40},"Tomasz Czarnik, MD, PhD",{"type":35,"investigatorFullName":107,"investigatorTitle":108,"investigatorAffiliation":5,"oldNameTitle":40,"oldOrganization":40},"Michał Borys","associate professor",[110,113],{"name":111,"class":112},"Nutricia Fundation","UNKNOWN",{"name":114,"class":112},"Catholic University of Lublin","100555803","diluted-and-undiluted-enteral-nutrition-100555803",false,"NCT06516835","Diluted and Undiluted Enteral Nutrition","The Influence of Diluted and Undiluted Enteral Nutrition on Nutritional Tolerance in Critically Ill Patients After Gastrointestinal Surgery - a Randomized Controlled Trial","Inclusion Criteria:\n\n* Scheduled for major abdominal surgery requiring ICU admission\n* Having access to the GI tract (gastric or jejunal)\n* Planned to be fed enterally\n\nExclusion Criteria:\n\n* Patients unable to give informed consent\n* After emergency surgeries\n* Without access to the GI tract\n* Individuals with contraindications to EN, such as short bowel syndrome, uncompensated shock, acidosis (pH \\\u003C 7.1; lactate \\> 5 mmol\u002Fl), bleeding from the upper GI tract, obstruction, intestinal ischemia, abdominal compartment syndrome\n* Patients with symptomatic gastro-esophageal reflux\n* Expected ICU stay \\\u003C 3 days\n* Pregnancy and lactation","ALL","18 Years","80 Years",{"count":126,"type":127},60,"ESTIMATED","INTERVENTIONAL",[130],"NA","Adult patients after elective major abdominal surgeries who are planned to be admitted to the Intensive Care Unit (ICU) can be included in the trial.\n\nEach patient will be fed via the gastrointestinal tract. Half of the patients will receive enteral nutrition (EN) with additional fluids, and the rest will receive undiluted EN.\n\nThe primary aim of this study is feeding intolerance assessment in both groups of patients.",[133,134,135,136,137],"Critical Illness","Surgery","Enteral Feeding Intolerance","Gastro-Intestinal Disorder","Quality of Life",[139,140,141,142],"Zonulin","Intestinal fatty-acid binding protein (I-FABP)","Ketones","Microbiome","NOT_YET_RECRUITING","2024-07-24",{"date":146,"type":147},"2024-07-26","ACTUAL",{"date":149,"type":127},"2025-01-02",{"date":151,"type":127},"2027-04-30",{"name":5,"class":6},5]